BioNTech (United States)

BioNTech (United States)

BioNTech SE is a global biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for BioNTech (United States), United States, covering academic research published from 2003 to 2024. Read More.


Open Access Percentage

69%


Total
Publications

120


Total Open
Publications

83


Total
Citations

4K


Open Access
Percentage

69%


Total
Publications

120


Total Open
Publications

83


Total
Citations

4K

Wikipedia

Website

download

Breakdown

22% 26% 21% 31%

Publisher Open

22%

Both

26%

Other Platform Open

21%

Closed

31%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618202224262830Total Publications
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

24%OA Journal

OA Journal 24%

14

Hybrid 50%

29

No Guarantees 26%

15

Other Platform Open

Preprint 50%

28

Domain 48%

27

Other Internet 23%

13

Public 7%

4

Institution 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
27
DOI
Other Internet
15
bioRxiv
Preprint
12
medRxiv
Preprint
7
Europe PMC
Domain
7
Figshare
Public
6
Research Square
Preprint
4
ChemRxiv
Preprint
4
Unknown Repository
Other Internet
1
OSF Preprints
Preprint
1
1 / 2

Data updated 13 February 2025

Share

Share

Share